Cerebral Somatic Oximeters Market, By Product Type (Dual Emitter and Dual Detector, Single Emitter and Dual Detector, and Others), By Patient Type (Pediatrics, Adults, and Others) By Application (Cardiac Surgery, Vascular Surgery, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Apr 2023

Code : CMI2659

Pages :165

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Cerebral Somatic Oximeters Market – Driver

Increasing prevalence of strokes

Increasing prevalence of stroke requires the use of cerebral somatic oximeters for the monitoring of patients, which is expected to drive the cerebral somatic oximeters market over the forecast period. For instance, in February 2022, data published by National Center for Biotechnology Information (NCBI), stated that the incidence of stroke ranges from 108 to 172 per 100,000 people per year in India.

Restraints & Challenges:

Disadvantages of cerebral somatic oximeters

Global Cerebral Somatic Oximeters Market: Key Developments

Increasing product approvals by regulatory authorities is expected to drive the global cerebral somatic oximeters market growth over the forecast period. For instance, in August 2020, Masimo, a global medical technology company, announced that O3 Regional Oximetry has received Food and Drugs Administration (FDA) clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.
In December 2021, Medtronic, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS 7100 cerebral/somatic oximetry system for children from birth through age 18.

Increasing prevalence of cardiac disorders

Increasing prevalence of cardiac disorders needs effective factors for the management of cardiac disorders which is expected to drive the cerebral somatic oximeters market growth over the forecast period. For instance, in June 2021, World Health Organization (WHO) stated that cardiovascular diseases (CVDs) are the leading cause of death, with 17.9 million deaths due to cardiovascular diseases globally, every year.

Global Cerebral Somatic Oximeters Market: Restraint

Disadvantages of cerebral somatic oximeters

The global cerebral somatic oximeters market can be hindered by the disadvantages of cerebral somatic disorders. For instance, in September 2021, according to a report published by National Center for Biotechnology Information (NCBI), the disadvantage of cerebral somatic oximeters is that the method is invasive, it is less sensitive to regional cerebral ischemia and hypoxia, etc.